Instruments & Photographic Equipment Formula 51-2 LLC agreed to acquire Motion DNA Corp through a tender offer Formula 51-2 LLC, an investment company based in Arizona, launched a tender offer to acquire Motion DNA Corp for approximately US$74.6 million in cash. Both companies agreed upon a price of US$3.125 for each share of Motion DNA common stock. The final agreement has now been signed and a formal vote on the issue by Motion DNA shareholders is scheduled. Motion DNA's goal is to reach US$100 Million in sales in a relatively short period of time and Formula 51-2 provides the capital required to support some of the proposals under review by potential clients and strategic partners. Motion DNA provides biomechanical analyses and detailed reports to its customers and consumers with solutions for preventing injuries, identifying physical limitations, diagnosing preexisting injuries related to biomechanics, and improving physical performance levels.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.